SCHEMBL4332885

SCHEMBL4332885

O=CN1CCC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8408343 0.87
SCHEMBL667439 0.83
SCHEMBL21617961 0.77
SCHEMBL756507 0.77 TRIM24 (0.43)
SCHEMBL3424537 0.77
SCHEMBL3431164 0.72
SCHEMBL56072 0.67 MAOA (0.54)
SCHEMBL3431239 0.65
SCHEMBL2373729 0.65
SCHEMBL383299 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4295852-A2 PIPERIDINE DERIVATIVES AS INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) Syros Pharmaceuticals, Inc. (US) 2023-12-27 EP claimed
EP-3484871-B1 PIPERIDINE DERIVATIVES AS INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS INC (US) 2023-06-07 EP claimed
US-20230062491-A1 INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) MEDIC LIFE SCIENCES, INC. 2023-03-02 US claimed
US-20230000870-A1 METHODS OF TREATING CANCER IN BIOMARKER-IDENTIFIED PATIENTS WITH INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) OXFORD FINANCE LLC, AS COLLATERAL AGENT 2023-01-05 US claimed
CN-114901284-A Methods of treating cancer in patients identified by biomarkers with cyclin dependent kinase 7(CDK7) inhibitors 希洛斯医药品股份有限公司 2022-08-12 CN claimed
WO-2021087138-A1 METHODS OF TREATING CANCER IN BIOMARKER-IDENTIFIED PATIENTS WITH INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS, INC. (US) 2021-05-06 WO claimed
EP-3484871-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) Syros Pharmaceuticals, Inc. (US) 2019-05-22 EP claimed
CN-109096415-A The preparation method of catalyst component for olefin polymerization and preparation method thereof and olefin polymerization catalysis and olefin polymer 中国石油化工股份有限公司 2018-12-28 CN claimed
CN-109096416-A The preparation method of catalyst component for olefin polymerization and preparation method thereof and olefin polymerization catalysis and olefin polymer 中国石油化工股份有限公司 2018-12-28 CN claimed
WO-2018013867-A1 INHIBITORS OF CYCLIN DEPENDNT KINASE 7 (CDK7) MARINEAU JASON J (US) 2018-01-18 WO claimed
CN-106242071-A Hexavalent chromium polluted composite resin adsorbent and preparation method thereof in a kind of steel and iron industry sewage 王维娜 2016-12-21 CN claimed
EP-4295852-A2 PIPERIDINE DERIVATIVES AS INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) Syros Pharmaceuticals, Inc. (US) 2023-12-27 EP disclosed
EP-3484871-B1 PIPERIDINE DERIVATIVES AS INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) SYROS PHARMACEUTICALS INC (US) 2023-06-07 EP disclosed
US-20230062491-A1 INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) MEDIC LIFE SCIENCES, INC. 2023-03-02 US disclosed
US-20230000870-A1 METHODS OF TREATING CANCER IN BIOMARKER-IDENTIFIED PATIENTS WITH INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) OXFORD FINANCE LLC, AS COLLATERAL AGENT 2023-01-05 US disclosed
WO-1998057937-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 WO disclosed
US-5468732-A Hypotensive PFIZER INC. (US) 1995-11-21 US disclosed
EP-0385593-A1 Phosphorus containing renin inhibitors PFIZER INC. (US) 1990-09-05 EP disclosed
WO-1990009172-A1 PHOSPHORUS CONTAINING RENIN INHIBITORS PFIZER INC. (US) 1990-08-23 WO disclosed
US-4003911-A ANTISECRETORY AGENTS, OXYTOCICS, BRONCHODILATORS, PLASTICIZERS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-01-18 US disclosed